EUVIMEDEUVIMED entdecken
Open Access

Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production

Elizabeth S York, Benjamin D Dratch, Jasmine Ito, Samantha M Horwitz, Sahand Emamian, Joseph A Ambarian, Surinder Gill, Jayre Jones, Satheesh Chonat, Pete Lollar, Shannon L Meeks, Katherine M Davis und 1 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2024.10.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Elizabeth S York und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Stanford University, Palo Alto, California, USA; Department of Pediatrics, Emory University, Atlanta, Georgia, USA; Aflac C…. Hauptthemen laut MEDLINE: Factor VIII, Hemophilia A, Immunoglobulin M, Spleen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Emory University, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The most significant treatment complication for patients with hemophilia A is the development of neutralizing immunoglobins (Igs) G, termed inhibitors, against factor VIII (FVIII), which prevent FVIII replacement therapy. Low titers of FVIII-specific IgMs have been identified in hemophilia A patients with and without inhibitors, as well as in healthy individuals. However, the duration and influence of IgMs on the immune response to FVIII remains unclear. OBJECTIVES: To characterize the binding interactions of persistently secreted FVIII-specific IgMs in hemophilia A mice and assess their effect on IgG antibody development. METHODS: Splenic-derived monoclonal antibodies (mAbs) from immunized FVIII knockout mice were isolated and purified using hybridoma technology. Binding interactions were assessed utilizing a novel fluid-phase enzyme-linked immunosorbent assay and computational modeling with High Ambiguity-Driven protein-protein DOCKing to account for weak IgM binding. RESULTS: Sixteen porcine cross-reactive and noninhibitory FVIII-specific IgM mAbs were identified. RNA sequencing of FVIII-specific IgMs revealed 13 unique variable, diversity, and joining (VDJ)/variable and joining (VJ) sequences indicating derivation from 13 unique B cell clones. The IgMs demonstrated polyclonal and polyreactive binding to FVIII in vitro and in silico. Molecular docking studies with reconstructed IgM variable, diversity, and joining/variable and joining regions identified frequent IgM interactions with amino acid residues K376, T381, K437, R2215, or K2249 within the FVIII A2 and C2 domains. Injections of individual IgMs prior to FVIII exposure and co-injection of FVIII/IgM immune complexes did not affect de novo FVIII antibody production. CONCLUSION: Persistent FVIII-specific IgMs are polyclonal but preferentially bind the A2 and C2 domains. FVIII/IgM immune complex formation does not significantly alter inhibitor development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIIHemophilia AImmunoglobulin MSpleenEpitopesAntibody FormationAnimalsMice, KnockoutMolecular Docking SimulationHumansAntibodies, MonoclonalProtein BindingCross ReactionsImmunoglobulin GMiceBinding Sites, AntibodyMice, Inbred C57BLProtein DomainsAntibodies, Neutralizing

Stichwörter der Autor:innen

blood coagulation factorsfactor VIIIhemophilia Ahumoral immune responseimmunoglobulin M

Substanzen

Factor VIIIImmunoglobulin MEpitopesAntibodies, MonoclonalF8 protein, humanImmunoglobulin GAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Pediatrics, Stanford University, Palo Alto, California, USA; Department of Pediatrics, Emory University, Atlanta, Georgia, USA; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, At…
  • Department of Chemistry, Emory University, Atlanta, Georgia, USA.
  • Department of Pediatrics, Emory University, Atlanta, Georgia, USA; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Physics, Emory University, Atlanta, Georgia, USA.
  • Department of Chemistry, Emory University, Atlanta, Georgia, USA. Electronic address: katherine.davis@emory.edu.

Förderung

  • NHLBI NIH HHS
  • Emory University
  • National Heart Lung and Blood Institute
  • Hemostasis and Thrombosis Research Society
  • Stanford University
  • Children's Healthcare of Atlanta
  • National Science Foundation
  • Hemophilia of Georgia

Zitieren

APA

York, E. S., Dratch, B. D., Ito, J., Horwitz, S. M., Emamian, S., Ambarian, J. A., Gill, S., Jones, J., Chonat, S., Lollar, P., Meeks, S. L., Davis, K. M., & Batsuli, G. (2025). Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.10.017

Vancouver

York ES, Dratch BD, Ito J, Horwitz SM, Emamian S, Ambarian JA, et al. Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.10.017

BibTeX
@article{York2025,
  author = {York, Elizabeth S and Dratch, Benjamin D and Ito, Jasmine and Horwitz, Samantha M and Emamian, Sahand and Ambarian, Joseph A and Gill, Surinder and Jones, Jayre and Chonat, Satheesh and Lollar, Pete and Meeks, Shannon L and Davis, Katherine M and Batsuli, Glaivy},
  title = {Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2024.10.017}
}
Kostenlos starten →